The HTC Bolt officially won’t be coming to Canada

The HTC Bolt is officially not heading to Canada, with a Sprint rep telling Mobile Syrup that “the HTC Bolt is a Sprint exclusive device and will only be available in the U.S.. It won’t be available in Canada”. But that doesn’t mean that the Bolt may not just assume a different name as it crosses the northern border…

According to some news , the HTC Bolt may still end up in Canada (and other global markets) under the moniker HTC 10 evo. Part HTC 10 and part Google Pixel, the HTC Bolt is a pretty nice looking phone even if it does have slightly watered down specs compared to those influences.

The HTC Bolt features a 5.5-inch QHD display, Snapdragon 810 chipset, 3 GB of RAM and 32 GB of built-in storage. On the camera front, the HTC Bolt packs a 16 MP main shooter with OIS and f/2.0 aperture along with a 8 MP front-facing selfie cam with a f/2.4 aperture.

The Bolt runs Android 7.0 Nougat out of the box and is powered by a 3,200 mAh battery that supports Qualcomm’s Quick Charge 2.0. The HTC Bolt does away with the beloved 3.5 mm headphone jack but adds an IP57 dust- and water-resistant rating to make up for it. The HTC Bolt also appeared with the world’s first “dual adaptive” USB Type-C headphones.

Would you buy the HTC Bolt under another name?

And please follow me on Google+ and please share it and Help me to make it better.

Comments

The Secret Science 02:The 30 Most Disturbing Human Experiments in History

Disturbing human experiments aren’t something the average person thinks too much about. Rather, the progress achieved in the last 150 years of human history is an accomplishment we’re reminded of almost daily. Achievements made in fields like biomedicine and psychology mean that we no longer need to worry about things like deadly diseases or masturbation as a form of insanity. For better or worse, we have developed more effective ways to gather information, treat skin abnormalities, and even kill each other. But what we are not constantly reminded of are the human lives that have been damaged or lost in the name of this progress. The following is a list of the 30 most disturbing human experiments in history. 30. The Tearoom Sex Study Sociologist Laud Humphreys often wondered about the men who commit impersonal sexual acts with one another in public restrooms. He wondered why “tearoom sex” — fellatio in public restrooms — led to the majority of homosexual arrests in ...

The Strange and Stranger Case of Wyndham Lathem

A Northwestern University plague researcher has been charged with a brutal murder. Here’s what we know about him. WIKIMEDIA, TONY WEBSTER O n July 27, The Chicago Tribune reported that there was an arrest warrant issued for Wyndham Lathem , a microbiologist at Northwestern University. The crime Lathem would later be charged with was brutal—26-year-old Trenton James Cornell-Duranleau, whose body was found in Lathem’s apartment, had been stabbed dozens of times. But Lathem was nowhere to be found. As events unfolded over the following days, it became clear he had fled from Chicago to California with a second suspect, 56-year-old Andrew Warren, a University of Oxford employee from the United Kingdom visiting the states. Along the way, the two men apparently made an anonymous $1,000 donation in Cornell-Duranleau’s name to the Lake Geneva Public Library and another donation for $5,610 to a Chicago health center. Lathem had also sent a video to fa...

Popular painkiller doesn’t have more heart risks than others, study claims

NEW ORLEANS — A long-awaited study on painkillers called nonsteroidal anti-inflammatory drugs, the most widely prescribed class of drugs in the world, has concluded that the three most commonly used carry a similar risk of cardiovascular complications. Yet critics say the study was too flawed to fairly compare them. Concerns about a type of NSAID called COX-2 inhibitors peaked in 2004 when the drug Vioxx was withdrawn from the market — a decision steeped in scandal because manufacturer Merck & Co had initially hidden data that would reveal the drug’s cardiovascular risks. A second COX-2 inhibitor, Pfizer Inc.’s Celebrex, was allowed to remain on the market with the condition that Pfizer conduct a study to prove that Celebrex was no worse than two older NSAIDs, naproxen and ibuprofen. The study lasted 10 years and enrolled more than 24,000 patients, but faced challenges. Doctors in European Union countries would not participate because they were worried a...

The Research

Search This Blog